Download Files:
Products Details
Product Description
– HBV-IN-24 (compound (2ʹS, 6S)-1a) is a potent HBV inhibitor. HBV-IN-24 exhibits potent inhibition activity against HBV DNA, HBsAg, and HBeAg, with EC50 values of 0.6, 0.6, and 4.6 nM, respectively. HBV-IN-24 shows excellent antiviral activity, could have improved neurotoxicity[1].
Web ID
– HY-147863
Shipping
– Room temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C23H27NO6
References
– [1]Qin X, et al. Identification of dihydroquinolizinone derivatives with cyclic ether moieties as new anti-HBV agents. Eur J Med Chem. 2022 Aug 5;238:114518.
Molecular Weight
– 413.46
SMILES
– COC1=C(C=C2C[C@H](N3C=C(C(C=C3C2=C1)=O)C(O)=O)C(C)C)OC[C@@H]4CCCO4
Clinical Information
– No Development Reported
Research Area
– Infection; Neurological Disease
Solubility
– 10 mM in DMSO
Target
– HBV
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
